Zepbound, Mounjaro Drug Shortages End

This is a news story, published by Yahoo, that relates primarily to Zepbound news.

Zepbound news

For more Zepbound news, you can click here:

more Zepbound news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Yahoo news

For more news from Yahoo, you can click here:

more news from Yahoo

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

loss drug Zepbound

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest FDA news, contract drug manufacturers news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Danish drugmaker Novo Nordisk

Reuters

•

US FDA says Lilly's weight-loss drug no longer in shortage

Summary

Nutrition label

81% Informative

Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, FDA says.

The FDA usually evaluates the market for a drug, and assesses whether all backorders have been filled for the drug before deciding on whether a shortage has been resolved.

As products move through the supply chain, patients and prescribers may still experience occasional local shortages.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech